Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Method for screening specific circular RNA (ribonucleic acid) of triple-negative breast cancer

A technology for triple-negative breast cancer, screening method, applied in the direction of biochemical equipment and methods, determination/inspection of microorganisms, etc.

Active Publication Date: 2017-10-17
重庆鼎晶医学检验所有限公司
View PDF1 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] So, can circular RNA become an entry point for the diagnosis and treatment of triple-negative breast cancer? In the prior art, research on triple-negative breast cancer-specific circular RNA is still blank

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for screening specific circular RNA (ribonucleic acid) of triple-negative breast cancer
  • Method for screening specific circular RNA (ribonucleic acid) of triple-negative breast cancer
  • Method for screening specific circular RNA (ribonucleic acid) of triple-negative breast cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0116] The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments.

[0117] A screening method for triple-negative breast cancer-specific circular RNA, the method comprising the following 5 steps:

[0118] (1) A number of sera from female patients with triple-negative breast cancer were selected as the experimental group A; normal female sera equal to the number of the experimental group A were selected as the control group B. In this embodiment, the serum of 15 female patients with triple-negative breast cancer was analyzed, and the serum of 15 normal female patients was used as a control. Select the dissolution and amplification curves in some experimental groups and control groups in the accompanying drawings, such as Figure 1-8 as shown, figure 1 is the amplification curve of experimental group 1; figure 2 It is the dissolution curve figure of experimental group 1; image 3 is the amplificati...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for screening specific circular RNA (ribonucleic acid) of triple-negative breast cancer. The method includes comparing circular gene expression of triple-negative breast cancer plasma samples and normal comparison groups by the aid of 70 parts of specific circular RNA of breast cancer; screening the specific circular RNA to obtain the circular RNA with functions of specifically obviously expressing the triple-negative breast cancer. The specific circular RNA is used as primers. The method has the advantage that results obtained by the aid of the method have important significance on triple-negative breast cancer diagnosis and treatment.

Description

technical field [0001] The invention relates to a screening method for tumor-specific circular RNA, in particular to a screening method for triple-negative breast cancer-specific circular RNA. Background technique [0002] Circular RNA (circular RNA) is a type of endogenous non-coding RNA different from linear RNA. It is a closed circular RNA molecule formed by back splicing and belongs to the non-coding RNA family. It is characterized by conservation, stability, specificity, and high content. It can be used as a microRNA sponge to regulate the activity of target miRNAs, and participate in the regulation of gene transcription and protein production. It has gradually become a new star in the non-coding RNA regulatory network. With the further advancement of RNA research technology, researchers have found that circular RNA plays an important role in the occurrence and development of cardiovascular system diseases, nervous system diseases, prion protein diseases and other disea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
CPCC12Q1/6811C12Q1/6886C12Q2600/178C12Q2531/113C12Q2563/107
Inventor 李丽仙辇伟奇林昌海张海伟唐超易琳冉静何永鹏唐万燕
Owner 重庆鼎晶医学检验所有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com